I'm not sure I understand you correctly. You have problems
I'm not sure I understand you correctly. You have problems with a vaccine from pharmaceutical companies that most all of us trust on a regular/daily basis for other medications, in my case that are keeping me alive? Vaccines that have been successfully trialed for Covid on tens of thousands of patients? And this during a pandemic that could eventually mutate completely out of control without aggressive resistant action from the majority of the world's population? But you appear to have no problem taking a MAB, modestly tested on a few hundred Covid patients. Produced by a pre-rev OTC with zero prior medical approval, or success, on anything? Would it be a different position if you had invested heavily in Pfizer instead of CYDY? If so did the investment change the science?
That you appear to base this perspective on information from nontraditional media sources makes perfect sense in our current world where one person's down is another person's up; an apparently expanding circumstance in our society.
Not being an MD I cannot speak to your wife's circumstances and perhaps I shouldn't be commenting at all, but connecting all the dots on vaccine attitudes, the politics of masks and social distancing, is all a bit perplexing to me.
I'll ask again. Who thinks more people are going to die from getting the vaccine than those who are going to die from not getting the vaccine? Anyone? Anyone? Bueller?
Obviously I share your confidence in LL/VX and would gladly take even for the low inflammation I currently maintain.
The very best to you and your wife and your investment in CYDY. Be well. Be safe. Be smart.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Nykredit Invest Balance Lifts Suspension for Investments It is with great news that Nykredit Portefølje Administration A/S has announced the suspension lift for several of its investment funds. Investors looking to engage their resources can now successfully allocate into the specified divisions. This significant step means investors can restart their activities in...
Continue Reading
Chaince Digital Holdings Completes Investment Round Chaince Digital Holdings Inc. (“Chaince” or the “Company”) (Nasdaq: CD), a leading fintech and digital asset-focused firm, has just finalized a private placement with institutional investors. This strategic move has brought in approximately US$6.14 million, underscoring robust investor confidence in the Company's...
Continue Reading
Alpha Modus Completes Merger with Insight Acquisition Corp Alpha Modus Holdings, Inc. is excited to share the successful closure of its business combination with Insight Acquisition Corp. This merger positions Alpha Modus to begin trading its common stock under the ticker symbol "AMOD" on the Nasdaq Global Market. Significance of the Business Combination This strategic...
Continue Reading
Overview of Olympic Steel's Financial Results Olympic Steel (ZEUS), a prominent metals service center, has recently reported its financial performance for the third quarter of 2024. The company achieved a net income of $2.7 million and an impressive earnings before interest, taxes, depreciation, and amortization (EBITDA) of $15 million. While these figures mark a decline...
Continue Reading
Lucid Software Recognized as a Top Innovator for 2025 Lucid Software, a prominent leader in visual collaboration, has been honored by Fast Company as one of the World's Most Innovative Companies for 2025. This acknowledgement emphasizes the company's dedication to revolutionizing team collaboration, enabling organizations to operate more efficiently and effectively....
Continue Reading